# Geron Corporation (GERN): Dividend & Fundamentals

> Markdown mirror of https://www.dividenddata.com/stocks/gern for AI agents. Same live data as the HTML page, regenerated on the same refresh cycle. Not investment advice.

- Sector: Healthcare · Industry: Biotechnology
- Exchange: NASDAQ · Trading currency: USD

Geron Corporation is an advanced-stage biopharmaceutical company dedicated to the creation and market introduction of treatments for myeloid blood cancers. Its primary drug candidate, imetelstat, is a telomerase inhibitor currently undergoing Phase 3 clinical evaluation. This therapy aims to suppress the unchecked proliferation of cancerous stem and progenitor cells characteristic of myeloid hematologic malignancies. Imetelstat is being developed to address low or intermediate-1 risk myelodysplastic syndromes and intermediate-2 or high-risk myelofibrosis. Established in 1990, Geron's corpor...

## Quote & Key Metrics

As of 2026-10-23:

| Metric | Value |
|---|---|
| Price | $1.12 USD |
| Market Cap | $719.6M |
| P/E (TTM) | — |
| EPS (TTM) | −$0.09 |
| 52-Week Range | $1.04 – $2.01 |
| Dividend Yield (TTM) | — |

## Dividend

GERN has no dividend payment history in our records.

## Frequently Asked Questions

### What does Geron Corporation do?

Geron Corporation (GERN) operates in the Biotechnology industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.

### What is GERN's market cap?

Geron Corporation (GERN) has a market capitalization of approximately $719.6 million, as of October 23, 2026, based on the most recent share price and shares outstanding.

### Does GERN pay a dividend?

No, Geron Corporation (GERN) does not currently pay a regular dividend. Many growth-stage companies reinvest earnings into the business instead of returning capital to shareholders. The Dividend tab tracks any future declarations.

### Is GERN profitable?

Geron Corporation (GERN) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.

### Has GERN ever paid a dividend?

No. Dividend Data's records show no dividend payments from Geron Corporation (GERN). A first dividend would appear on the Dividend tab once it is declared.

## More on Dividend Data

- Overview (HTML): https://www.dividenddata.com/stocks/gern
- Dividend history & safety: https://www.dividenddata.com/stocks/gern/dividend
- Earnings & EPS: https://www.dividenddata.com/stocks/gern/earnings
- Financial statements: https://www.dividenddata.com/stocks/gern/financials/income
- Valuation multiples: https://www.dividenddata.com/stocks/gern/valuation
- Peer comparison: https://www.dividenddata.com/stocks/gern/peers

Data sourced from primary filings and market data providers; see https://www.dividenddata.com/methodology.